Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Surrozen, Inc.

NASDAQ: SRZN · Life Sciences · 7 alerts · CIK 1824893

Surrozen, Inc. stories on ALFA USA NewsRead the news →
Share price
$32.32Close, Nov 16
Market cap
$616M
Shares outstanding
19.06MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Surrozen, Inc. filings on SEC EDGAR ↗

5:03 PM ET 10-Q
Financial Results ▶ Call

Surrozen Q3 2026 Results: Net Loss of $130M, Loss Widens

Surrozen, Inc. reported a net loss of $207.1 million for the nine months ended September 30, 2026, significantly higher than the $58.9 million loss in the prior year period, primarily driven by a $111.5 million loss on the change in fair value of tranche liabilities. Total revenue for the nine-month period was $10.0 million, derived from collaboration and license revenue, while operating expenses increased to $48.5 million due to higher research and development costs.

Key figure
Net loss $130M
4:19 PM ET 8-K
Financial Results

Surrozen Financial Results

Surrozen reported Q3 2026 financial results and announced the expansion of its Phase 2a DUET study for SZN-8141 from 60 to 150 patients. The company strengthened its balance sheet in October 2026 by closing a $95.1 million private placement tranche and raising $29.8 million via its ATM program, extending its cash runway into 2029.

Term
Q3 2026

“We have made important progress advancing Surrozen into its next stage of development, with the first patient dosed in the SZN-8141 DUET study and plans to significantly expand Phase 2a enrollment from approximately 60 to 150 patients. The additional capital raised in October positions us to generate a more robust clinical dataset across a broader DME population, while maintaining anticipated cash runway into 2029.”

Craig Parker, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.